
QX-314 bromide ,24003-58-5 |
||||||
Cat.No.:IC-0356953 |
||||||
Product Information |
||||||
Biological Activity |
||||||
QX-314 bromide is a membrane-impermeable permanently charged sodium channel blocker. |
||||||
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines) |
||||||
Species |
Mouse |
Rat |
Rabbit |
Guinea pig |
Hamster |
Dog |
Weight (kg) |
0.02 |
0.15 |
1.8 |
0.4 |
0.08 |
10 |
Body Surface Area (m2) |
0.007 |
0.025 |
0.15 |
0.05 |
0.02 |
0.5 |
Km factor |
3 |
6 |
12 |
8 |
5 |
20 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by (Animal B Km / Animal A Km) |
||||||
Order Information |
||||||
|
Quantity |
Price($) |
Price(€) |
Price(£¤/CNY) |
||
10mg |
$53.00 |
€63.60 |
£¤530.00 |
|||
50mg |
$211.00 |
€253.20 |
£¤2,110.00 |
|||
100mg |
$378.00 |
€453.60 |
£¤3,780.00 |
|||
Free Delivery on orders over $350.00. |
||||||
Chemical Information |
||||||
Molecular Weight |
343.3 |
|||||
Formula |
C16H27BrN2O |
|||||
CAS Number |
24003-58-5 |
|||||
Purity |
>98.00% |
|||||
Solubility |
H2O : 100 mg/mL (291.29 mM) |
|||||
Storage |
4¡ãC, protect from light |
|||||
Reference |
||||||
[1]. Rivera-Acevedo RE, et al. The quaternary lidocaine derivative, QX-314, exerts biphasic effects on transient receptor potential vanilloid subtype 1 channels in vitro. Anesthesiology. 2011 Jun;114(6):1425-34. |
||||||
We Devoted Ourselves To The Development Of Biomedical Research Reagent. |
||||||